XML 65 R42.htm IDEA: XBRL DOCUMENT v3.25.4
Stock-Based Compensation (Tables)
 12 Months Ended
Dec. 31, 2025
Share-Based Payment Arrangement [Abstract]  
Schedule of Stock-based Compensation Expense, Net of Forfeitures and Adjustments
The Company recorded stock-based compensation expense for the years ended December 31, 2025, 2024, and 2023, net of forfeitures and adjustments, in the consolidated statements of operations as follows:

(in thousands)202520242023
Cost of sales$1,194 $759 $942 
General and administrative23,961 19,655 9,199 
Sales and marketing1,333 1,077 1,650 
Research and development4,157 2,996 2,500 
Total$30,645 $24,487 $14,291 
Schedule of Information With Respect to Stock Options
The below tables present information with respect to stock options:
(in thousands, except for exercise price)Number of SharesWeighted
Average
Exercise Price		Aggregate
 Intrinsic Value
Outstanding at January 1, 2025714 $13.36 
Options granted134 $38.70 
Options exercised(35)$13.40 
Options canceled/forfeited(1)$16.99 
Outstanding at December 31, 2025812 $17.54 $15,547 
Vested and expected to vest at December 31, 2025812 $17.54 $15,547 
Total shares exercisable at December 31, 2025678 $13.35 $15,547 

(in thousands, except for grant date fair value)202520242023
Option expense recorded for the year ended December 31,$138 $507 $2,813 
Weighted average grant date fair value$22.52 $— $— 
Total intrinsic value of stock options exercised for the year ended December 31,$1,397 $6,745 $2,700 
Cash received for options exercised$466 $2,235 $1,069 
Schedule of Assumptions for Fair Value of Options at the Date of the Grant
The issuance date fair value of the Warrant extension was determined to be $4.5 million based on using the Black-Scholes model with the following assumptions as of January 2, 2024:

Original WarrantModified Warrant
Expected term2.25 years4.25 years
Risk free interest rate4.33 %3.93 %
Expected volatility55.01 %63.39 %
Expected dividend yieldNoneNone
Fair value (per warrant)$7.36 $16.21 
The fair value of options at the date of the grant was estimated using the Black-Scholes model with the following assumptions for the period ending December 31, 2025:

2025
Expected option life6.0 years
Weighted average risk-free interest rate3.8 %
Weighted average expected volatility58.9 %
Expected dividend yieldNone
Schedule of Share-based Compensation by Exercise Price Range Stock options outstanding at December 31, 2025 are summarized as follows:
Range of exercise pricesNumber outstanding (in thousands)Weighted average remaining life
$0.73 - $38.70
812 4.94 years
Summary of Restricted Stock Awards Activity
Current year activity with respect to the Company’s non-vested RSUs is as follows:

(in thousands, except weighted average fair value)SharesWeighted Average grant- date fair value
Balance at January 1, 20251,122 $47.21 
Granted542 $67.77 
Vested(482)$44.27 
Canceled/forfeited(96)$54.61 
Balance at December 31, 20251,086 $59.59 

The below table presents information with respect to RSUs:

(in thousands)202520242023
Service-based RSU$19,566 $12,723 $9,189 
Performance-based RSU8,355 8,969 2,257 
Total stock-based compensation expense related to RSUs$27,921 $21,692 $11,446